SML Biopharm

South Korea
Gwangmyeong, Gyeonggi-do, South Korea

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$3M
Last funding
Corporate Round / $3M / 2023-12-07
Last equity funding
Corporate Round / $3M
Investors
1
Lead investors
1
Articles
3

Founders and investors

Lead investors

Raphas

Investors

Raphas